Evaluation of regulatory genetic variants in POU5F1 and risk of congenital heart disease in Han Chinese.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4623744)

Published in Sci Rep on October 28, 2015

Authors

Yuan Lin1,2, Chenyue Ding1,3, Kai Zhang1,2, Bixian Ni1,2, Min Da4, Liang Hu4, Yuanli Hu4, Jing Xu5, Xiaowei Wang5, Yijiang Chen5, Xuming Mo4, Yugui Cui3, Hongbing Shen1,2, Jiahao Sha1,6, Jiayin Liu1,3, Zhibin Hu1,2

Author Affiliations

1: State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, China.
2: Department of Epidemiology and Biostatistics and Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
3: Clinical Center of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
4: Department of Cardiothoracic Surgery, Nanjing Children's Hospital, Nanjing Medical University, Nanjing 210008, China.
5: Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
6: Department of Histology and Embryology, Nanjing Medical University, Nanjing 210029, China.

Articles cited by this

Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell (2008) 28.29

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05

A protein interaction network for pluripotency of embryonic stem cells. Nature (2006) 9.63

The developmental genetics of congenital heart disease. Nature (2008) 4.61

Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol (2011) 4.48

Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol (2008) 4.30

Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 3.90

Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr (2008) 3.87

An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell (2010) 3.60

Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem Sci (1998) 2.71

The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J Biol Chem (2002) 2.03

The changing epidemiology of congenital heart disease. Nat Rev Cardiol (2010) 1.99

Genetics of congenital heart disease: the glass half empty. Circ Res (2013) 1.90

Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet (2005) 1.76

C/EBP transcription factors mediate epicardial activation during heart development and injury. Science (2012) 1.48

Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell (2006) 1.44

The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.43

Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet (2011) 1.35

A genome-wide association study identifies two risk loci for congenital heart malformations in Han Chinese populations. Nat Genet (2013) 1.19

Of mice and men: molecular genetics of congenital heart disease. Cell Mol Life Sci (2013) 1.10

Genetic basis of congenital cardiovascular malformations. Eur J Med Genet (2014) 1.00

The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol (2010) 0.96

A molecular and genetic outline of cardiac morphogenesis. Acta Physiol (Oxf) (2013) 0.95

Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects. Circ J (2012) 0.91

Nongenetic risk factors and congenital heart defects. Pediatr Cardiol (2013) 0.90

Oct4 is required ~E7.5 for proliferation in the primitive streak. PLoS Genet (2013) 0.89